Investors & Media

News

HomeInvestors & MediaNews

NEOK Bio Initiates Phase 1 Clinical Trials of Both Lead Bispecific ADCs
2026-05-27ablbio
list
PREV
Poster Presentations Highlight Strong Preclinical Data and Differentiated Profile of ABL206 and ABL209 at AACR
NEXT

ABL Bio

메뉴닫기